Pathophysiology, Clinical Characteristics of Diabetic Cardiomyopathy: Therapeutic Potential of Natural Polyphenols
Diabetic cardiomyopathy (DCM) is an outcome of disturbances in metabolic activities through oxidative stress, local inflammation, and fibrosis, as well as a prime cause of fatality worldwide. Cardiovascular disorders in diabetic individuals have become a challenge in diagnosis and formulation of tre...
Main Authors: | Neha Atale, Dhananjay Yadav, Vibha Rani, Jun-O Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2020.564352/full |
Similar Items
-
An Investigation of Fibulin-2 in Hypertrophic Cardiomyopathy
by: Ayman M. Ibrahim, et al.
Published: (2020-09-01) -
Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue
by: Angela Serena Maione, et al.
Published: (2020-04-01) -
Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate
by: Amir M. Al Hroob, et al.
Published: (2019-01-01) -
The Mitochondria: A Target of Polyphenols in the Treatment of Diabetic Cardiomyopathy
by: Humna Bhagani, et al.
Published: (2020-07-01) -
ERK1/2: An Integrator of Signals That Alters Cardiac Homeostasis and Growth
by: Christopher J. Gilbert, et al.
Published: (2021-04-01)